Get live help whenever you need it.

Schedule a call with a friendly support specialist when it's convenient for you

We can provide answers to questions about ENBREL treatment and support programs

Our registered nurses are available 8 AM to 11 PM (ET), 7 days a week, and our insurance and general information specialistsare available 8 AM to 8 PM (ET), Monday through Friday. Live support is available in over 200 languages. If this is a medical emergency, please call 911.Please only request this call regarding your treatment or the treatment of a child in your care.

Patient Information

Indicates Required Field

First Name

Last Name

E-mail Address

Verify E-mailAddress

Phone Number

Call Information

What type of assistance would you like?

Select a time zone

When would you like us to call?

As soon as possible

Estimated callback time: about an hour

We appreciate your patience.

At this time, we may not be able to get back to you until tomorrow.If you would like a scheduled appointment, please click below.

You scheduled a call for Monday, March 1st at 9:15 am (ET).

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.

ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.

Psoriatic Arthritis

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.

Ankylosing Spondylitis (AS)

ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

Moderate to Severe Plaque Psoriasis

ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.